Skip to content

Clinical trials

Amyloidosis trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Country / region: Argentina Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20082
20111
20132
20141
20151
20161
20193
20201
20221
20231
20244
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting7
Active, not recruiting2
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals7
Ionis Pharmaceuticals, Inc.5
Pfizer4
Hospital Italiano de Buenos Aires2
Intellia Therapeutics2
Alexion Pharmaceuticals, Inc.1
Eidos Therapeutics, a BridgeBio company1
Hospital de Alta Complejidad en Red1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis23
Amyloid Neuropathies, Familial9
Cardiomyopathies7
Polyneuropathies6
Amyloidosis, Familial5
Alzheimer Disease4
Amyloid Neuropathies2
Metabolism, Inborn Errors2
Rare Diseases2
Adrenal Hyperplasia, Congenital1

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.